Quantcast
Last updated on April 24, 2014 at 1:21 EDT

Latest Ivax Corporation Stories

2013-09-25 23:26:05

Reportbuyer.com just published a new market research report: Pharma Leader Series: Top Pharma Contract Manufacturing Organisations (CMOs) 2013-2023. London (PRWEB) September 25, 2013 Report Details Contract manufacturing for pharma - discover top companies' revenue prospects How are pharma contract manufacturing organisations (CMOs) performing? Visiongain's new report shows you their prospects to 2023. There you see results, trends, opportunities, and revenue predictions. Our...

2013-02-26 12:21:57

Rock Hill Chemical Distribution Plant Bought, Fixed Up after Sitting Vacant Over a Decade ROCK HILL, S.C., Feb. 26, 2013 /PRNewswire/ -- A few blocks from the intersection of Dave Lyle Blvd and the US 21 Bypass sit two weathered buildings. Contractors, workers and inspectors flow in and out. The buildings are getting a much needed facelift from their new owner after sitting vacant for over a decade. Formerly home to an Ivax Corporation specialty chemical plant, the over 18,000 square...

2012-03-08 09:00:00

BOCA RATON, Fla., March 8, 2012 /PRNewswire/ -- Biotest Pharmaceuticals Corporation (BPC), a wholly-owned subsidiary of Biotest AG (Dreieich, Germany), announced the appointment of Jordan Siegel as the Company's Chief Executive Officer, effective May 1, 2012. Dr. Georg Floss, BPC's interim CEO, will be returning to Germany on April 30th after successfully completing his assignment to assume the role of Global Head of Operations for Biotest AG. "I would like to thank Dr. Floss for his...

2010-09-28 12:42:00

BONITA SPRINGS, Fla., Sept. 28 /PRNewswire/ -- Tigris Pharmaceuticals, Inc., a privately held drug development company, is pleased to announce the appointment of Mr. Neil Flanzraich as Executive Chairman of the Board of Directors. "The appointment of Mr. Flanzraich is a very important milestone for Tigris Pharmaceuticals' future," said Edmundo Muniz, MD, PhD, President and CEO of Tigris, adding, "Neil brings to Tigris extraordinary ability and pharmaceutical industry experience and a...

2009-11-03 12:34:00

U.S. Also Files Complaint Against Two Atlanta-Based Nursing Home Chains And Their Principals WASHINGTON, Nov. 3 /PRNewswire-USNewswire/ -- The nation's largest nursing home pharmacy, Omnicare Inc. of Covington, Kentucky, will pay $98 million, and drug manufacturer, IVAX Pharmaceuticals of Weston, Florida, will pay $14 million to resolve allegations that Omnicare engaged in kickback schemes with several parties, including IVAX, the Justice Department announced today. Approximately $68.5...

2009-02-24 10:33:00

WASHINGTON, Feb. 24 /PRNewswire-USNewswire/ -- Teva Pharmaceuticals USA, the leading generic pharmaceutical company, today released the second in a series of videos as part of the "Year of Affordable Healthcare" campaign. The video, entitled "Where Am I?" (available at www.yearofaffordablehealth.com/gallery) is meant to illustrate the important savings generic drugs have produced for everyday Americans since the passage of Waxman-Hatch 25 years ago. Teva's "Year of Affordable Healthcare"...

2008-10-22 06:00:22

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that it will release its third quarter 2008 financial results on Thursday, November 6, 2008. Teva will host a conference call and live webcast on the same day, at 8:00 a.m. ET to discuss its third quarter 2008 results and overall business environment. A Question & Answer session will follow this discussion. The earnings release will be available on Teva's web site at www.tevapharm.com prior to the call. Investors...

2008-07-23 03:00:58

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that it has completed its acquisition of Bentley Pharmaceuticals, Inc. (NYSE: BNT), which will operate in Spain under the Teva name. At closing, Bentley consisted solely of its generic pharmaceutical operations, following the spin-off of its drug delivery business to its stockholders on June 30, 2008. The aggregate purchase price paid by Teva was approximately $360 million in cash, or approximately $14.82 per Bentley share....

2008-07-19 00:00:17

Significantly Strengthens Teva's Market Leadership Position in the U.S. and in Key Global Markets Acquisition Expected to Be Accretive in the Fourth Quarter after Closing Teva Investors: Elana Holzman, 972 (3) 926-7554 elana.holzman@teva.co.il or Media: Ayala Miller, 972 (3) 926-7262 ayala.miller@teva.co.il or Kevin Mannix, 215-591-8912 kevin.mannix@tevausa.com or Denise Bradley, 215-591-8974 denise.bradley@tevausa.com or Barr Investors and Media: Carol...

2008-07-14 03:00:39

Teva Pharmaceutical Industries Ltd. (NASDAQ: TEVA) announced today that it will release its second quarter 2008 financial results on Tuesday, July 29, 2008. Teva will host a conference call and live webcast on that same day, at 8:30 a.m. ET to discuss its second quarter 2008 results and overall business environment. A Question & Answer session will follow this discussion. The earnings release will be available on Teva's web site at www.tevapharm.com prior to the call. Investors...